Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines

Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19, is currently developing into a rapidly disseminating and an overwhelming worldwide pandemic. In severe COVID-19 cases, hypercoagulability and inflammation are two crucial complications responsible for poor prog...

Full description

Bibliographic Details
Main Authors: Mohamed S. Abdel-Bakky, Elham Amin, Mohamed G. Ewees, Nesreen I. Mahmoud, Hamdoon A. Mohammed, Waleed M. Altowayan, Ahmed A. H. Abdellatif
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Viruses
Subjects:
hypercoagulability
COVID-19
natural anticoagulants
nanoparticles
targeting
COVID-19 vaccines
Online Access:https://www.mdpi.com/1999-4915/14/2/228

Internet

https://www.mdpi.com/1999-4915/14/2/228

Similar Items